Wednesday - September 9, 2026
Institute for Clinical and Economic Review to Assess Gene Therapy for Huntington's Disease
August 20, 2026
BOSTON, Massachusetts, Aug. 20 -- The Institute for Clinical and Economic Review issued the following news release:

* * *

Institute for Clinical and Economic Review to Assess Gene Therapy for Huntington's Disease

-- Report will be subject of Midwest CEPAC meeting in March 2027; Draft Scoping Document open to public comment until September 11, 2026 --

-

The Institute for Clinical and Economic Review (ICER) announced today that . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products